Search Count: 7
 |
Organism: Ensifer aridi
Method: X-RAY DIFFRACTION Resolution:1.36 Å Release Date: 2024-06-12 Classification: ANTIVIRAL PROTEIN Ligands: ZN |
 |
Organism: Ensifer aridi
Method: X-RAY DIFFRACTION Resolution:1.68 Å Release Date: 2024-06-12 Classification: ANTIVIRAL PROTEIN Ligands: ZN |
 |
Organism: Ensifer aridi
Method: X-RAY DIFFRACTION Resolution:2.68 Å Release Date: 2024-06-12 Classification: ANTIVIRAL PROTEIN Ligands: ZN |
 |
Organism: Ensifer aridi
Method: X-RAY DIFFRACTION Resolution:2.47 Å Release Date: 2024-06-12 Classification: ANTIVIRAL PROTEIN Ligands: ZN |
 |
The Structure Of Nica2 Variant F104L/A107T/S146I/G317D/H368R/L449V/N462S From Pseudomonas Putida
Organism: Pseudomonas putida s16
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2023-07-26 Classification: FLAVOPROTEIN Ligands: FDA |
 |
The Structure Of Nica2 Variant F104L/A107T/S146I/G317D/H368R/L449V/N462S In Complex With N-Methylmyosmine
Organism: Pseudomonas putida s16
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-07-26 Classification: FLAVOPROTEIN Ligands: NCT, FDA, EDO |
 |
Organism: Pseudomonas putida
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2023-07-26 Classification: FLAVOPROTEIN, OXIDOREDUCTASE Ligands: FDA, PG4, PEG, TXU |